A Study to Assess the Safety and Efficacy of Leuprorelin in Central Precocious Puberty in Chinese Participants

Status:
Completed

Trial end date:
2018-11-23

Target enrollment:

Participant gender:

The purpose of this study is to assess long-term safety and efficacy of leuprorelin in the treatment of Central Precocious Puberty (CPP).

Phase 4

Takeda

Leuprolide